In closing arguments, the defence called for a lighter sentence than the four-years imprisonment requested by prosecutors.
Judge Claude Veillard said the ruling would be made on December 10.
The month-long trial in Marseille saw prosecutor Jacques Dallest also calling for PIP founder Jean-Claude Mas to pay a USD 130,000 fine and to be banned from working in medical services or from running a company.
Five PIP executives are on trial in the case including the 73-year-old Mas, charged with aggravated fraud for using industrial-grade silicone in implants.
The prosecutor called for prison terms of between six months and two years for the other defendants.
Mas, speaking in court to his four co-accused, said he regretted "the manner in which PIP had to wind up."
"A large percentage of the victims had NuSil gel (which is made by a California company which can be used in medical applications) in their implants," he said. Mas reiterated that the gel used by his company was "not toxic or dangerous."
They were conducted by the independent laboratory LEMI (Laboratory in charge of Evaluating Implant Materials).
"About 50 tests were conducted between 2002 until 2008. I am not saying this to defend Mr Mas, I am saying this for you," Haddad said, referring to the victims.
News of the faulty implants in 2011 sparked fears worldwide, but health officials in various countries have said they were not toxic and did not increase the risk of breast cancer.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
